Company Analysis

TransCode Therapeutics, Inc. (RNAZ)

Nasdaq: RNAZ · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2020
Grade2.9
◀ Past 2.4● Present 1.7▶ Future 4.3
6 est.

Filings

281 filings since 2017 beside 43 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jun 2, 2026.

Filings a yearinsider forms included
1414176634953
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Debt trigger or default notice (8-K item 2.04): 1 time in the last 36 months, the newest Oct 1, 2026.Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Sep 11, 2026.Listing warning from its exchange (8-K item 3.01): 7 times in the last 36 months, the newest May 26, 2026.SEC letters: 10 in the last 36 months, the newest May 15, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.
Insider forms 43

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 28, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 1, 2026 8-K items 1.01, 2.04 Major agreement signed; Debt trigger or default notice · Current report
Sep 28, 2026 8-K items 8.01, 9.01 Other event · Current report
Sep 11, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Sep 9, 2026
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Aug 3, 2026 SCHEDULE 13D/A Activist holder update, amended
Aug 3, 2026 8-K items 3.03, 5.03, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Jul 28, 2026 SCHEDULE 13G Large holder notice
Jul 28, 2026 SCHEDULE 13G Large holder notice
Jul 28, 2026 SCHEDULE 13G Large holder notice
Jul 27, 2026 SCHEDULE 13D/A Activist holder update, amended
Jul 23, 2026 SCHEDULE 13D/A Activist holder update, amended
Jul 20, 2026 424B3 Shelf offering
Jul 20, 2026 424B3 Shelf offering
Jul 20, 2026 8-K item 5.07 Shareholder vote · Current report
Jul 17, 2026 SCHEDULE 13D/A Activist holder update, amended
Jul 17, 2026 DEFA14A Extra proxy material
Jul 17, 2026 8-K items 3.03, 5.03, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Jul 16, 2026
Jul 2, 2026 8-K item 8.01 Other event · Current report
Jun 18, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jun 3, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 2, 2026 ARS Annual report to shareholders Dec 31, 2025
Jun 2, 2026 DEF 14A Proxy statement Jul 2, 2026
Jun 1, 2026 8-K item 5.08 item 5.08 · Current report May 29, 2026
May 26, 2026 DEFA14A Extra proxy material
May 26, 2026 8-K/A item 3.01 Listing warning from its exchange · Current report, amended May 19, 2026
May 22, 2026 8-K item 3.01 Listing warning from its exchange · Current report May 19, 2026
May 19, 2026 EFFECT Registration effective
May 19, 2026 EFFECT Registration effective
May 15, 2026 CORRESP Reply to the SEC
May 15, 2026 CORRESP Reply to the SEC
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 8, 2026 PRE 14A Preliminary proxy statement
May 6, 2026 UPLOAD SEC comment letter
May 6, 2026 UPLOAD SEC comment letter
May 1, 2026 S-1 Listing registration
Apr 30, 2026 S-3 Shelf registration
Apr 30, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 20, 2026 SCHEDULE 13G Large holder notice
Apr 15, 2026 10-K Annual report Dec 31, 2025
40 of 281 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton RNAZ · research, not advice